Morphing from Mærsk Logistics to Mærsk Forwarding?
Let’s look
Pharma is “a growth market” for ocean carriers as shippers become cost- and emissions-conscious, but temperature and time-sensitive requirements could mean a liner’s “piece of the pie” will only be a sliver.
Cathy O’Brien, VP of international sales at UPS Healthcare, told The Loadstar the demand for cold-chain transportation and handling was “growing rapidly”.
“If we look to the future, more than half of the drugs in development are biologics, which require development in cold chain and temperature monitoring services… the ...
Volcanic disruption at Anchorage could hit transpacific airfreight operations
Macron calls for ‘suspension’ – CMA CGM's $20bn US investment in doubt
De minimis exemption on shipments from China to the US will end in May
Forwarders stay cool as US 'liberation day' tariffs threaten 'global trade war'
Trump tariffs see hundreds of cancelled container bookings a day from Asia
Mixed response in US to 'Liberation Day', while China leads wave of retaliation
Tariffs and de minimis set air freight rates on a volatile course
Overcapacity looms for ocean trades – with more blanked sailings inevitable
East-west rates diverge as transpac spots hold while Asia-Europe keeps falling
Temu and DHL join forces to expand non-US ecommerce sales
Purchase of Panama railway 'a significant opportunity' for ambitious APMT
'To ship or not to ship', the question for US importers amid tariff uncertainty
Survey results: the biggest concerns for forwarders and shippers in 2025
DHL Capital Markets Day – Scharwath steals the show, plays down size concern
'No lookouts on either ship' says MAIB report on box ship-tanker collision
Comment on this article
Karen Betancourt
August 06, 2024 at 2:32 pmFascinating place to key an eye on. My concern is whether insurance limits will keep up, as the average biologic is even more expensive per manufacturer WAC than name brands.